157 related articles for article (PubMed ID: 36709124)
1. [Clinicopathological analysis of superior mediastinal lymph node metastases in medullary thyroid carcinoma].
He YY; Chen YT; Wang J; Chen MQ; Zhu YM; Ni S; Liu SY
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):82-87. PubMed ID: 36709124
[No Abstract] [Full Text] [Related]
2. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
Ye L; Zhou X; Lu J; Wang Y; Xie X; Zhang J
J Clin Lab Anal; 2020 Jul; 34(7):e23278. PubMed ID: 32141647
[TBL] [Abstract][Full Text] [Related]
3. Measuring discrepancies between simple medullary and synchronous medullary/papillary thyroid carcinomas: a comparative cross-sectional study.
Zhang D; Yang M; Frattini F; Cestari A; Li K; Wang H; Chi H; Sui C; Bai K; Lan D; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1301200. PubMed ID: 38317715
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Lateral Lymph Node Metastases in Patients With Sporadic Medullary Thyroid Carcinoma.
Wu X; Li B; Zheng C; Liu W; Hong T; He X
Technol Cancer Res Treat; 2020; 19():1533033820962089. PubMed ID: 32964812
[TBL] [Abstract][Full Text] [Related]
5. Combination of ultrasound and serological tests for detecting occult lateral lymph node metastases in medullary thyroid cancer.
Xiao J; Jiang J; Chen W; Hong T; Li B; He X; Liu W
Cancer Med; 2023 May; 12(10):11417-11426. PubMed ID: 37004158
[TBL] [Abstract][Full Text] [Related]
6. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
Terroir M; Caramella C; Borget I; Bidault S; Dromain C; El Farsaoui K; Deandreis D; Grimaldi S; Lumbroso J; Berdelou A; Hadoux J; Hescot S; Hartl D; Baudin E; Schlumberger M; Leboulleux S
Thyroid; 2019 Oct; 29(10):1457-1464. PubMed ID: 31530235
[No Abstract] [Full Text] [Related]
7. Preoperative calcitonin testing improves the diagnosis of medullary thyroid carcinoma in female and male patients.
Weber T; Poplawski A; Vorländer C; Dotzenrath C; Ringelband R; Schabram J; Passler C; Zielke A; Schlegel N; Nies C; Krenz D; Jähne J; Schwab R; Bartsch DK; Binnebösel M; Kemen M; Klinger C; Buhr H; Lorenz K
Eur J Endocrinol; 2022 Jan; 186(2):223-231. PubMed ID: 34871180
[TBL] [Abstract][Full Text] [Related]
8. Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma.
Fan W; Xiao C; Wu F
J Int Med Res; 2018 May; 46(5):1982-1989. PubMed ID: 29569965
[TBL] [Abstract][Full Text] [Related]
9. [Cervical lymph node metastasis in medullary thyroid carcinoma].
Yan D; Zhang B; Li Z; Wu Y; Liu S; Liu W; Xu Z; Tang P
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Apr; 50(4):290-4. PubMed ID: 26081082
[TBL] [Abstract][Full Text] [Related]
10. Prediction of biochemical cure in patients with medullary thyroid cancer.
Machens A; Lorenz K; Dralle H
Br J Surg; 2020 May; 107(6):695-704. PubMed ID: 32108330
[TBL] [Abstract][Full Text] [Related]
11. [Prediction and investigation of the potential risk factors for the upper mediastinal metastasis of papillary thyroid carcinoma].
Liu Y; Xu SY; Liu K; Wang XL; Liu SY; Xu ZG; Liu J
Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):477-483. PubMed ID: 33902211
[No Abstract] [Full Text] [Related]
12. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
Jin LX; Moley JF
Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of management of superior mediastinal metastasis from thyroid carcinoma with systemic superior mediastinal dissection via sternotomy approach: 12 cases report].
Zhang Q; Guo ZM; Fu JH; Zeng ZY; Chen FJ; Wei MW; Wu GH; Yang AK
Ai Zheng; 2004 Jul; 23(7):842-4. PubMed ID: 15248925
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
[TBL] [Abstract][Full Text] [Related]
15. Metastatic Risk Profile of Microscopic Lymphatic and Venous Invasion in Medullary Thyroid Cancer.
Machens A; Lorenz K; Weber F; Dralle H
Horm Metab Res; 2021 Sep; 53(9):588-593. PubMed ID: 34496409
[TBL] [Abstract][Full Text] [Related]
16. Prediction of mediastinal lymph node metastasis in medullary thyroid carcinoma.
Machens A; Holzhausen HJ; Dralle H
Br J Surg; 2004 Jun; 91(6):709-12. PubMed ID: 15164439
[TBL] [Abstract][Full Text] [Related]
17. Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer.
Machens A; Lorenz K; Dralle H
Br J Surg; 2019 Mar; 106(4):412-418. PubMed ID: 30725475
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of mediastinal lymph node dissection through sternotomy approach in the treatment of papillary thyroid carcinoma with mediastinal lymph node metastasis].
Shao K; Gao SG; Xue Q; Gao YS; Li J; Wang YG; Li ZS; Lei WD; Wang B; Feng FY; Lyu F; Chen XJ; Xu ZG; Liu WS; Liu SY; Wang XL; Li ZJ; Liu J; He J
Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(24):1866-1871. PubMed ID: 32575929
[No Abstract] [Full Text] [Related]
19. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract][Full Text] [Related]
20. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
